224047-41-0
中文名稱
3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇
英文名稱
1-[2-(4-CHLOROPHENYL)-1-(1-HYDROXY-1-PHENYLETHYL)ETHYL]-1,2,4-TRIAZOLE
CAS
224047-41-0
分子式
C18H18ClN3O
分子量
327.81
MOL 文件
224047-41-0.mol
更新日期
2026/02/12 14:46:38
224047-41-0 結(jié)構(gòu)式
基本信息
中文別名
蕓苔素吡咯(RAC)-蕓苔素唑
4-(4-氯苯基)-2-苯基-3-(1H-1,2,4-三唑-1-基)丁-2-醇
3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇
英文別名
BRZBRASSINAZOLE
Brassinazole >
(Rac)-Brassinazole
1-[2-(4-Chlorophenyl)-1-(1-hydroxy-1-phenylethyl)e
4-(4-chlorophenyl)-2-phenyl-3-(1,2,4-triazol-1-yl)-2-butanol
4-(4-Chlorophenyl)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)butan-2-ol
1-[2-(4-CHLOROPHENYL)-1-(1-HYDROXY-1-PHENYLETHYL)ETHYL]-1,2,4-TRIAZOLE
3-(4-CHLOROPHENYL)-1-METHYL-1-PHENYL-2-(1,2,4-TRIAZOL-1-YL)-1-PROPANOL
1H-1,2,4-Triazole-1-ethanol, β-[(4-chlorophenyl)methyl]-α-methyl-α-phenyl-
所屬類別
有機(jī)原料：雜環(huán)化合物物理化學(xué)性質(zhì)
沸點(diǎn)533.1±60.0 °C(Predicted)
密度1.22
儲(chǔ)存條件-20°C儲(chǔ)存
溶解度DMF: 100 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 50 mg/ml; Ethanol: 25 mg/ml
酸度系數(shù)(pKa)13.11±0.29(Predicted)
形態(tài)粉末晶體
顏色白色到黃色到橙色
InChIInChI=1S/C18H18ClN3O/c1-18(23,15-5-3-2-4-6-15)17(22-13-20-12-21-22)11-14-7-9-16(19)10-8-14/h2-10,12-13,17,23H,11H2,1H3
InChIKeyYULDTPKHZNKFEY-UHFFFAOYSA-N
SMILESC(CC1C=CC(=CC=1)Cl)(C(C)(O)C1C=CC=CC=1)N1C=NC=N1
CAS 數(shù)據(jù)庫(kù)224047-41-0
3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇價(jià)格(試劑級(jí))
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2026/07/06 | S6781 | 3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇 Brassinazole | 224047-41-0 | 5mg | 1090.13元 |
| 2026/07/06 | S6781 | 3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇 Brassinazole | 224047-41-0 | 25mg | 2667.54元 |
| 2026/06/06 | B2829 | 蕓苔素唑 Brassinazole | 224047-41-0 | 10MG | 640元 |
常見問題列表
生物活性
Brassinazole (BRZ)是一種有效的油菜素類固醇 brassinosteroid (BR) 生物合成抑制劑，IC50值約1 μM，可用于探測(cè)油菜素類固醇的多種功能。油菜素類固醇是一類植物激素，在植物生長(zhǎng)和發(fā)育（包括促進(jìn)莖伸長(zhǎng)和細(xì)胞分裂）中起著重要作用。靶點(diǎn)
| Target | Value |
|
brassinosteroid
(Cell-free assay) | 1 μM |
體外研究
(Rac)-Brassinazole (compound 5) does not retard rice stem elongation, and retardation is recovered by the addition of gibberellin (GA3), suggesting that such retardation is due to the inhibition of gibberellin biosynthesis.
(Rac)-Brassinazol (compound 31) results in a reduction in the effect on AtKO in gibberellin (GA) biosynthesis.